Citigroup
SIOX

Citigroup’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Citigroup’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5
Closed -$18 – 7836
2019
Q4 		$0 Sell
5
-594
-99% -$3.29K ﹤0.01% 7861
2019
Q3 		$4K Sell
599
-952
-61% -$6.56K ﹤0.01% 7419
2019
Q2 		$9K Sell
1,551
-3,449
-69% -$26.3K ﹤0.01% 7350
2019
Q1 		$53K Buy
5,000
+2,796
+127% +$27.8K ﹤0.01% 6299
2018
Q4 		$18K Buy
2,204
+441
+25% +$6.36K ﹤0.01% 6934
2018
Q3 		$34K Sell
1,763
-150
-8% -$2.73K ﹤0.01% 6823
2018
Q2 		$35K Sell
1,913
-14,883
-89% -$220K ﹤0.01% 6564
2018
Q1 		$178K Buy
16,796
+9,976
+146% +$160K ﹤0.01% 5085
2017
Q4 		$287K Sell
6,820
-8,684
-56% -$390K ﹤0.01% 4693
2017
Q3 		$854K Sell
15,504
-12,282
-44% -$2.07M ﹤0.01% 3547
2017
Q2 		$5.16M Buy
27,786
+27,763
+120,709% +$4.87M ﹤0.01% 1671
2017
Q1 		$3K Sell
23
-1,666
-99% -$175K ﹤0.01% 6957
2016
Q4 		$168K Buy
1,689
+1,418
+523% +$149K ﹤0.01% 5431
2016
Q3 		$30K Sell
271
-57
-17% -$6.84K ﹤0.01% 5991
2016
Q2 		$34K Sell
328
-1,135
-78% -$113K ﹤0.01% 5818
2016
Q1 		$134K Buy
1,463
+929
+174% +$99.1K ﹤0.01% 5449
2015
Q4 		$77K Buy
+534
New +$69.5K ﹤0.01% 5591
2015
Q3 		– Hold
0
– – – 7838

Other funds holding SIOX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Citigroup's SIOX Position: Q1 2020 in Review

Citigroup sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2020, closing a stake of 5 shares — an estimated $18 sold.

Citigroup first reported a position in SIOX in Q4 2015 and held it in 17 quarters. The position peaked at $5.16M in Q2 2017. 42 funds tracked by Wall St. Rank hold SIOX as of Q1 2020.

  • Citigroup reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Citigroup sold 5 Sio Gene Therapies Inc. Common Stock shares in Q1 2020, an estimated $18.
  • Citigroup first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 17 quarters.
  • Citigroup's Sio Gene Therapies Inc. Common Stock position peaked at $5.16M in Q2 2017.
  • 42 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2020.

Based on Citigroup's 13F filing for Q1 2020, filed 12 May 2020.